Annual Shareholders Equity
$70.08 M
-$20.75 M-22.85%
September 30, 2024
Summary
- As of February 22, 2025, CTXR annual stockholders equity is $70.08 million, with the most recent change of -$20.75 million (-22.85%) on September 30, 2024.
- During the last 3 years, CTXR annual shareholders equity has fallen by -$62.10 million (-46.98%).
- CTXR annual shareholders equity is now -46.98% below its all-time high of $132.18 million, reached on September 30, 2021.
Performance
CTXR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$65.41 M
-$4.67 M-6.66%
December 31, 2024
Summary
- As of February 22, 2025, CTXR quarterly stockholders equity is $65.41 million, with the most recent change of -$4.67 million (-6.66%) on December 31, 2024.
- Over the past year, CTXR quarterly shareholders equity has dropped by -$20.28 million (-23.66%).
- CTXR quarterly shareholders equity is now -52.15% below its all-time high of $136.68 million, reached on June 30, 2021.
Performance
CTXR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTXR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -23.7% |
| 3 y3 years | -47.0% | -23.7% |
| 5 y5 years | +158.1% | -23.7% |
CTXR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.0% | at low | -47.2% | at low |
| 5 y | 5-year | -47.0% | +158.1% | -52.1% | +221.0% |
| alltime | all time | -47.0% | +9545.7% | -52.1% | +4213.2% |
Citius Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $65.41 M(-6.7%) |
| Sep 2024 | $70.08 M(-22.8%) | $70.08 M(-18.2%) |
| Jun 2024 | - | $85.68 M(+8.0%) |
| Mar 2024 | - | $79.37 M(-6.3%) |
| Dec 2023 | - | $84.73 M(-6.7%) |
| Sep 2023 | $90.83 M(-11.7%) | $90.83 M(-7.0%) |
| Jun 2023 | - | $97.70 M(+7.1%) |
| Mar 2023 | - | $91.21 M(-9.2%) |
| Dec 2022 | - | $100.43 M(-2.3%) |
| Sep 2022 | - | $102.83 M(-6.3%) |
| Sep 2022 | $102.83 M(-22.2%) | - |
| Jun 2022 | - | $109.74 M(-6.7%) |
| Mar 2022 | - | $117.60 M(-5.1%) |
| Dec 2021 | - | $123.96 M(-6.2%) |
| Sep 2021 | $132.18 M(+292.6%) | $132.18 M(-3.3%) |
| Jun 2021 | - | $136.68 M(+9.2%) |
| Mar 2021 | - | $125.16 M(+396.7%) |
| Dec 2020 | - | $25.20 M(-25.2%) |
| Sep 2020 | $33.67 M(+24.0%) | $33.67 M(+17.1%) |
| Jun 2020 | - | $28.74 M(+28.1%) |
| Mar 2020 | - | $22.44 M(+10.1%) |
| Dec 2019 | - | $20.38 M(-25.0%) |
| Sep 2019 | $27.15 M(-2.6%) | $27.15 M(+26.3%) |
| Jun 2019 | - | $21.51 M(+3.0%) |
| Mar 2019 | - | $20.87 M(-13.7%) |
| Dec 2018 | - | $24.18 M(-13.2%) |
| Sep 2018 | $27.87 M | $27.87 M(+28.8%) |
| Jun 2018 | - | $21.64 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $23.50 M(-9.1%) |
| Dec 2017 | - | $25.86 M(+17.8%) |
| Sep 2017 | $21.95 M(+30.9%) | $21.95 M(+89.3%) |
| Jun 2017 | - | $11.59 M(-17.1%) |
| Mar 2017 | - | $13.99 M(-7.7%) |
| Dec 2016 | - | $15.16 M(-9.6%) |
| Sep 2016 | $16.77 M(-2739.5%) | $16.77 M(-7.7%) |
| Jun 2016 | - | $18.16 M(-11.1%) |
| Mar 2016 | - | $20.43 M(-1384.5%) |
| Dec 2015 | - | -$1.59 M(+150.3%) |
| Sep 2015 | -$635.20 K(-14.4%) | -$635.20 K(-46.2%) |
| Jun 2015 | - | -$1.18 M(+28.6%) |
| Mar 2015 | - | -$918.00 K(+11.5%) |
| Dec 2014 | - | -$823.50 K(+11.0%) |
| Sep 2014 | -$741.90 K(+4946.9%) | -$741.90 K(+2262.7%) |
| Jun 2014 | - | -$31.40 K(+25.1%) |
| Mar 2014 | - | -$25.10 K(+67.3%) |
| Dec 2013 | - | -$15.00 K(+2.0%) |
| Sep 2013 | -$14.70 K(-67.9%) | -$14.70 K(-76.3%) |
| Jun 2013 | - | -$61.90 K(+7.7%) |
| Mar 2013 | - | -$57.50 K(+21.6%) |
| Dec 2012 | - | -$47.30 K(+3.3%) |
| Sep 2012 | -$45.80 K(+92.4%) | -$45.80 K(+13.1%) |
| Jun 2012 | - | -$40.50 K(+20.5%) |
| Mar 2012 | - | -$33.60 K(+27.3%) |
| Dec 2011 | - | -$26.40 K(+10.9%) |
| Sep 2011 | -$23.80 K | -$23.80 K(+12.8%) |
| Jun 2011 | - | -$21.10 K |
FAQ
- What is Citius Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual shareholders equity year-on-year change?
- What is Citius Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Citius Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CTXR is $70.08 M
What is the all time high annual shareholders equity for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual stockholders equity is $132.18 M
What is Citius Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CTXR annual stockholders equity has changed by -$20.75 M (-22.85%)
What is Citius Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CTXR is $65.41 M
What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly stockholders equity is $136.68 M
What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CTXR quarterly stockholders equity has changed by -$20.28 M (-23.66%)